| Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance Y Chu, E Dai, Y Li, G Han, G Pei, DR Ingram, K Thakkar, JJ Qin, M Dang, ... Nature medicine 29 (6), 1550-1562, 2023 | 103 | 2023 |
| The evolution pathway of ammonia-oxidizing archaea shaped by major geological events Y Yang, C Zhang, TM Lenton, X Yan, M Zhu, M Zhou, J Tao, TJ Phelps, ... Molecular Biology and Evolution 38 (9), 3637-3648, 2021 | 36 | 2021 |
| Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression R Wang, S Song, J Qin, K Yoshimura, F Peng, Y Chu, Y Li, Y Fan, J Jin, ... Cancer cell 41 (8), 1407-1426. e9, 2023 | 34 | 2023 |
| MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers O Alhalabi, J Chen, Y Zhang, Y Lu, Q Wang, S Ramachandran, ... Nature communications 13 (1), 1797, 2022 | 34 | 2022 |
| Detecting prognosis risk biomarkers for colon cancer through multi-omics-based prognostic analysis and target regulation simulation modeling Z Yin, X Yan, Q Wang, Z Deng, K Tang, Z Cao, T Qiu Frontiers in Genetics 11, 524, 2020 | 29 | 2020 |
| Identification of toxic pyrrolizidine alkaloids and their common hepatotoxicity mechanism X Yan, H Kang, J Feng, Y Yang, K Tang, R Zhu, L Yang, Z Wang, Z Cao International Journal of Molecular Sciences 17 (3), 318, 2016 | 25 | 2016 |
| In Silico Insight into Potential Anti-Alzheimer’s Disease Mechanisms of Icariin Z Cui, Z Sheng, X Yan, Z Cao, K Tang International Journal of Molecular Sciences 17 (1), 113, 2016 | 14 | 2016 |
| H-RACS: a handy tool to rank anti-cancer synergistic drugs X Yan, Y Yang, Z Chen, Z Yin, Z Deng, T Qiu, K Tang, Z Cao Aging (Albany NY) 12 (21), 21504, 2020 | 11 | 2020 |
| A phase II trial evaluating combination pemetrexed and avelumab in patients with MTAP-deficient advanced urothelial cancer. AY Shah, MT Campbell, R Tidwell, AO Siefker-Radtke, S Goswami, ... Journal of Clinical Oncology 40 (16_suppl), TPS4612-TPS4612, 2022 | 1 | 2022 |
| Reveal the regulation patterns of prognosis-related miRNAs and lncRNAs across solid tumors in the Cancer Genome Atlas Z Yin, Q Wang, X Yan, L Zhang, K Tang, Z Cao, T Qiu Frontiers in Cell and Developmental Biology 8, 368, 2020 | 1 | 2020 |
| Study of synergistic mechanism in the combination ofberberine and evodiamine from the perspective of miRNA Z Yin, Z Cao, X Yan, Y Yang, Z Sheng Chinese Pharmacological Bulletin, 772-780, 2017 | 1 | 2017 |
| METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics J Jiang, Y Liu, J Qin, J Chen, J Wu, MP Pizzi, R Lazcano, K Yamashita, ... Nature Communications 15 (1), 7312, 2024 | | 2024 |
| iStarTLS: Advanced detection and phenotyping of tertiary lymphoid structures KS Cho, J Jiang, D Zhang, Y Liu, J Chen, RL Segura, X Yan, G Pei, ... Cancer Research 84 (6_Supplement), 7424-7424, 2024 | | 2024 |
| SpatialCS: A tool to effectively integrate histological annotations and spatial transcriptomics analysis Y Chu, KS Cho, I Khanduri, T Zhou, J Jiang, Y Liu, X Yan, G Pei, Y Dai, ... Cancer Research 84 (6_Supplement), 7417-7417, 2024 | | 2024 |
| MorphLink: Bridging Cell Morphological Behaviors and Molecular Dynamics in Multi-modal Spatial Omics J Huang, C Yuan, J Jiang, J Chen, S Badve, Y Gokmen-Polar, RL Segura, ... bioRxiv, 2024.08. 24.609528, 2024 | | 2024 |
| 660 Phase 2 Study to evaluate the triplet combination of pemetrexed plus etrumadenant and zimberelimab in patients with previously treated advanced or MTAP-deficient metastatic … O Alhalabi, R Sheth, A Shah, T Bathala, SP Klimkowsky, W Qiao, J Chen, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Evolution of immune and stromal cell states during the gastric cancer continuum R Wang, S Song, J Qin, K Yoshimura, F Peng, Y Chu, Y Li, Y Fan, J Jin, ... Cancer Research 83 (7_Supplement), 1194-1194, 2023 | | 2023 |
